As our gene identification efforts continue to evolve, COGA has initiated efforts to combine genetic information with known environmental risk factors to predict risk for substance use disorders in clinical and population‐based samples. 134 , 135 Although these are not yet ready for integration into clinical practice, we have begun to lay the groundwork for the utilization of genetic risk information by reviewing the current status of genetic feedback for psychiatric conditions, 136 studying public interest in receiving personalized genetic risk scores, 137 and examining how we can return complex risk information in ways that will promote healthy behavior. 138
